Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Teams With Pear Therapeutics In Neurological Digital Health Pact

Executive Summary

Duo aims to get Pear's THRIVE digital therapeutic approved, and to develop a new application to treat MS patients, then seek validation in clinical studies.

Advertisement

Related Content

Finance Watch: Former Juno Execs Launch Sana With Allogeneic Cell Therapy Platform
Pharma’s Digital Directive: Not If, But How
Deal Watch: Gilead’s Immunology Collaboration With Verily Continues Pivot Away From Virology
What Will Novartis Do With $13bn Cash Pile From GSK?
Digital Deals And Life Sciences: Avoiding Death By A Thousand Pilots
Digital Gets Top Billing As Novartis CEO Wields Management Broom
Deal Watch: Roivant Adds Ligand's Glucose Receptor Antagonist To Metavant Pipeline
Interview: Novartis Takes Virtual Route To Transform Clinical Trial Paradigm

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100486

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel